(5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

Decarboxylation of the Catalytic Lysine Residue by the C5 alpha-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the OXA-58 Carbapenemase.

MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYI
PASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQ
IGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL

0.2 M sodium acetate, 0.1 M Tris-HCl pH 8.5, 30% PEG4000

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

beta-lactamase, carbapenemase, antibiotic resistance, inhibitor, HYDROLASE, HYDROLASE-INHIBITOR complex